'holistas-viral-protection-products-in-demand' - googling it will bring up the link.

Holista’s viral protection sanitiser products in demand

By Trevor Hoey. Published at May 13, 2020, in ASX Biotechs

Shares in Holista Colltech Limited (ASX:HCT) hit a high of 18 cents on Tuesday after the company announced that it had appointed OOH Medical Ltd as exclusive distributor for the Natshield^TM sanitiser products for the United Kingdom for an initial term of 3 years, with minimum orders for the first year to be negotiated in the coming weeks.

At one stage, the company’s shares were up nearly 10% which was a strong performance on a day when the broader market was down as much as 90 points.

OOH Medical shares common equity shareholders with Health Therapies LLC, the group’s exclusive distributor of Natshield^TM in the US.

The group has submitted an official tender application to supply Natshield_^TM to the UK government.

Pending formal approval of this application, it will be conducting market research, test advertising and marketing to create and oversee promotional campaigns.

OOH Medical expects to receive registration of Natshield^TM from Medicines and Healthcare products Regulatory Agency, (MHRA) in the UK by July 2020.

With the registration and confirmation of all relevant legal and compliance procedures, OOH Medical will be able to market all Natshield^TM products through their distribution channels in the UK, including the NHS, e-commerce, health stores and pharmacies.

Holista’s March quarter cash inflows were nearly $2 million, up from approximately $1.7 million in the March quarter of 2019.

With the UK still in the grip of the coronavirus, there should be strong ongoing demand for Holista’s products.

I wonder what is the follow up here.